SoundCure launches Serenade tinnitus treatment system in the UK
22 April 2013
SoundCure Inc. has announced the launch of the Serenade tinnitus
treatment system that offers
tinnitus sufferers potential relief using S-Tones, customized
treatment sounds developed by leading hearing
researchers at the University of California.
Tinnitus, or “ringing ears” affects approximately 10% of UK
adults and an estimated 260 million people globally. It can be
extremely debilitating, leading to depression, irritability, and
difficulty sleeping or concentrating.
is a handheld device that is programmed in the clinician’s office
for each individual patient according to his specific condition.
Through the device’s earphones, the patient listens to therapeutic
sounds which are designed to address the underlying neurological
cause of tinnitus. Four different treatment sounds are available,
anchored by advanced, proprietary S-Tones. Long-term relief can be
achieved when used in an ongoing sound therapy program.
Sound therapy as a tinnitus treatment is well-established and
effective. S-Tones are low frequency, amplitude modulated tones that
are frequency pitch-matched to a patient’s unique tinnitus,
representing a significant clinical breakthrough compared to
previous approaches. According to Dr Fan-Gang Zeng, one of the
technology inventors, these modulated tones “keep the brain’s
interest” thus “reducing the perceived tinnitus sound and bringing
relief”. In addition, S-Tones are intended to be “listened to at a
volume that is lower than the patient’s tinnitus, reducing the sound
burden,” according to Dr. Zeng.